Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

PERL in Diabetes Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.

Afkarian M, Polsky S, Parsa A, Aronson R, Caramori ML, Cherney DZ, Crandall JP, de Boer IH, Elliott TG, Galecki AT, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Lingvay I, Maahs DM, McGill JB, Molitch ME, Perkins BA, Pop-Busui R, Pragnell M, Rosas SE, Rossing P, Senior P, Sigal RJ, Spino C, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M, Doria A; PERL Study Group.

Diabetes Care. 2019 Jun 11. pii: dc190342. doi: 10.2337/dc19-0342. [Epub ahead of print]

PMID:
31186299
2.

Repeatability of brown adipose tissue measurements on FDG PET/CT following a simple cooling procedure for BAT activation.

Crandall JP, Gajwani P, O JH, Mawhinney DD, Sterzer F, Wahl RL.

PLoS One. 2019 Apr 17;14(4):e0214765. doi: 10.1371/journal.pone.0214765. eCollection 2019.

3.

Measurement Repeatability of 18F-FDG-PET/CT versus 18F-FDG-PET/MRI in Solid Tumors of the Pelvis.

Fraum TJ, Fowler KJ, Crandall JP, Laforest RA, Salter A, An H, Jacobs MA, Grigsby PW, Dehdashti F, Wahl RL.

J Nucl Med. 2019 Feb 7. pii: jnumed.118.218735. doi: 10.2967/jnumed.118.218735. [Epub ahead of print]

PMID:
30733325
4.

Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials.

Bhasin S, Ellenberg SS, Storer TW, Basaria S, Pahor M, Stephens-Shields AJ, Cauley JA, Ensrud KE, Farrar JT, Cella D, Matsumoto AM, Cunningham GR, Swerdloff RS, Wang C, Lewis CE, Molitch ME, Barrett-Connor E, Crandall JP, Hou X, Preston P, Cifelli D, Snyder PJ, Gill TM.

Lancet Diabetes Endocrinol. 2018 Nov;6(11):879-890. doi: 10.1016/S2213-8587(18)30171-2.

PMID:
30366567
5.

Lessons From the Testosterone Trials.

Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Resnick SM, Budoff M, Mohler ER 3rd, Wenger NK, Cohen HJ, Schrier S, Keaveny TM, Kopperdahl D, Lee D, Cifelli D, Ellenberg SS.

Endocr Rev. 2018 Jun 1;39(3):369-386. doi: 10.1210/er.2017-00234.

6.

Measurement of Brown Adipose Tissue Activity Using Microwave Radiometry and 18F-FDG PET/CT.

Crandall JP, O JH, Gajwani P, Leal JP, Mawhinney DD, Sterzer F, Wahl RL.

J Nucl Med. 2018 Aug;59(8):1243-1248. doi: 10.2967/jnumed.117.204339. Epub 2018 Feb 9.

7.

Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults.

Kulkarni AS, Brutsaert EF, Anghel V, Zhang K, Bloomgarden N, Pollak M, Mar JC, Hawkins M, Crandall JP, Barzilai N.

Aging Cell. 2018 Apr;17(2). doi: 10.1111/acel.12723. Epub 2018 Jan 31.

8.

The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials.

Mohler ER 3rd, Ellenberg SS, Lewis CE, Wenger NK, Budoff MJ, Lewis MR, Barrett-Connor E, Swerdloff RS, Stephens-Shields A, Bhasin S, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Gill TM, Matsumoto AM, Molitch ME, Pahor M, Preston PE, Hou X, Cifelli D, Snyder PJ.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):681-688. doi: 10.1210/jc.2017-02243.

9.

Metformin and vitamin B12-What's missing from this picture?

Crandall JP.

J Diabetes Complications. 2018 Feb;32(2):129. doi: 10.1016/j.jdiacomp.2017.11.003. Epub 2017 Nov 27. No abstract available.

PMID:
29175118
10.

Statin use and risk of developing diabetes: results from the Diabetes Prevention Program.

Crandall JP, Mather K, Rajpathak SN, Goldberg RB, Watson K, Foo S, Ratner R, Barrett-Connor E, Temprosa M.

BMJ Open Diabetes Res Care. 2017 Oct 10;5(1):e000438. doi: 10.1136/bmjdrc-2017-000438. eCollection 2017. Erratum in: BMJ Open Diabetes Res Care. 2017 Oct 25;5(1):e000438corr1.

11.

Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.

Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM; Diabetes Prevention Program Research Group.

Diabetologia. 2017 Sep;60(9):1601-1611. doi: 10.1007/s00125-017-4361-9. Epub 2017 Aug 2. Review.

12.

Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.

Goldberg RB, Aroda VR, Bluemke DA, Barrett-Connor E, Budoff M, Crandall JP, Dabelea D, Horton ES, Mather KJ, Orchard TJ, Schade D, Watson K, Temprosa M; Diabetes Prevention Program Research Group.

Circulation. 2017 Jul 4;136(1):52-64. doi: 10.1161/CIRCULATIONAHA.116.025483. Epub 2017 May 5.

13.

Association of Family History of Exceptional Longevity With Decline in Physical Function in Aging.

Ayers E, Barzilai N, Crandall JP, Milman S, Verghese J.

J Gerontol A Biol Sci Med Sci. 2017 Nov 9;72(12):1649-1655. doi: 10.1093/gerona/glx053.

14.

Clinical Trials Targeting Aging and Age-Related Multimorbidity.

Espeland MA, Crimmins EM, Grossardt BR, Crandall JP, Gelfond JA, Harris TB, Kritchevsky SB, Manson JE, Robinson JG, Rocca WA, Temprosa M, Thomas F, Wallace R, Barzilai N; Multimorbidity Clinical Trials Consortium.

J Gerontol A Biol Sci Med Sci. 2017 Mar 1;72(3):355-361. doi: 10.1093/gerona/glw220.

15.

Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults.

Pollack RM, Barzilai N, Anghel V, Kulkarni AS, Golden A, O'Broin P, Sinclair DA, Bonkowski MS, Coleville AJ, Powell D, Kim S, Moaddel R, Stein D, Zhang K, Hawkins M, Crandall JP.

J Gerontol A Biol Sci Med Sci. 2017 Nov 9;72(12):1703-1709. doi: 10.1093/gerona/glx041.

16.

Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment.

Resnick SM, Matsumoto AM, Stephens-Shields AJ, Ellenberg SS, Gill TM, Shumaker SA, Pleasants DD, Barrett-Connor E, Bhasin S, Cauley JA, Cella D, Crandall JP, Cunningham GR, Ensrud KE, Farrar JT, Lewis CE, Molitch ME, Pahor M, Swerdloff RS, Cifelli D, Anton S, Basaria S, Diem SJ, Wang C, Hou X, Snyder PJ.

JAMA. 2017 Feb 21;317(7):717-727. doi: 10.1001/jama.2016.21044.

17.

Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.

Budoff MJ, Ellenberg SS, Lewis CE, Mohler ER 3rd, Wenger NK, Bhasin S, Barrett-Connor E, Swerdloff RS, Stephens-Shields A, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Gill TM, Matsumoto AM, Molitch ME, Nakanishi R, Nezarat N, Matsumoto S, Hou X, Basaria S, Diem SJ, Wang C, Cifelli D, Snyder PJ.

JAMA. 2017 Feb 21;317(7):708-716. doi: 10.1001/jama.2016.21043.

18.

Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial.

Roy CN, Snyder PJ, Stephens-Shields AJ, Artz AS, Bhasin S, Cohen HJ, Farrar JT, Gill TM, Zeldow B, Cella D, Barrett-Connor E, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Lewis CE, Matsumoto AM, Molitch ME, Pahor M, Swerdloff RS, Cifelli D, Hou X, Resnick SM, Walston JD, Anton S, Basaria S, Diem SJ, Wang C, Schrier SL, Ellenberg SS.

JAMA Intern Med. 2017 Apr 1;177(4):480-490. doi: 10.1001/jamainternmed.2016.9540.

19.

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC.

Crandall JP, Tahari AK, Juergens RA, Brahmer JR, Rudin CM, Esposito G, Subramaniam DS, Knopp MV, Hall NC, Gajwani P, Leal JP, Lodge MA, O JH, Gabrielson EW, Shankar LK, Wahl RL.

EJNMMI Res. 2017 Dec;7(1):8. doi: 10.1186/s13550-017-0258-3. Epub 2017 Jan 19.

20.

Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.

Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Bhasin S, Matsumoto AM, Parsons JK, Gill TM, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Gallagher L, Zeldow B, Lewis CE, Pahor M, Swerdloff RS, Hou X, Anton S, Basaria S, Diem SJ, Tabatabaie V, Ellenberg SS, Snyder PJ.

J Clin Endocrinol Metab. 2016 Aug;101(8):3096-104. doi: 10.1210/jc.2016-1645. Epub 2016 Jun 29.

21.

Metformin as a Tool to Target Aging.

Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA.

Cell Metab. 2016 Jun 14;23(6):1060-1065. doi: 10.1016/j.cmet.2016.05.011. Review.

22.

New Locus for Skin Intrinsic Fluorescence in Type 1 Diabetes Also Associated With Blood and Skin Glycated Proteins.

Roshandel D, Klein R, Klein BE, Wolffenbuttel BH, van der Klauw MM, van Vliet-Ostaptchouk JV, Atzmon G, Ben-Avraham D, Crandall JP, Barzilai N, Bull SB, Canty AJ, Hosseini SM, Hiraki LT, Maynard J, Sell DR, Monnier VM, Cleary PA, Braffett BH; DCCT/EDIC Research Group, Paterson AD.

Diabetes. 2016 Jul;65(7):2060-71. doi: 10.2337/db15-1484. Epub 2016 Apr 12.

23.

Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study.

Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, Bray GA, Schade DS, Temprosa MG, White NH, Crandall JP; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2016 Apr;101(4):1754-61. doi: 10.1210/jc.2015-3754. Epub 2016 Feb 22.

24.

Effects of Testosterone Treatment in Older Men.

Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Cifelli D, Dougar D, Fluharty L, Resnick SM, Storer TW, Anton S, Basaria S, Diem SJ, Hou X, Mohler ER 3rd, Parsons JK, Wenger NK, Zeldow B, Landis JR, Ellenberg SS; Testosterone Trials Investigators.

N Engl J Med. 2016 Feb 18;374(7):611-24. doi: 10.1056/NEJMoa1506119.

25.

Recruitment and Screening for the Testosterone Trials.

Cauley JA, Fluharty L, Ellenberg SS, Gill TM, Ensrud KE, Barrett-Connor E, Cifelli D, Cunningham GR, Matsumoto AM, Bhasin S, Pahor M, Farrar JT, Cella D, Rosen RC, Resnick SM, Swerdloff RS, Lewis CE, Molitch ME, Crandall JP, Stephens-Shields AJ, Strorer TW, Wang C, Anton S, Basaria S, Diem S, Tabatabaie V, Dougar D, Hou X, Snyder PJ.

J Gerontol A Biol Sci Med Sci. 2015 Sep;70(9):1105-11. doi: 10.1093/gerona/glv031. Epub 2015 Apr 15.

26.

Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials.

Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Ellenberg SS, Matsumoto AM, Bhasin S, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Fluharty L, Gill TM, Lewis CE, Pahor M, Resnick SM, Storer TW, Swerdloff RS, Anton S, Basaria S, Diem S, Tabatabaie V, Hou X, Snyder PJ.

J Clin Endocrinol Metab. 2015 Mar;100(3):1146-55. doi: 10.1210/jc.2014-3818. Epub 2014 Dec 30.

27.

Long-term prevalence and predictors of urinary incontinence among women in the Diabetes Prevention Program Outcomes Study.

Phelan S, Kanaya AM, Ma Y, Vittinghoff E, Barrett-Connor E, Wing R, Kusek JW, Orchard TJ, Crandall JP, Montez MG, Brown JS; Diabetes Prevention Program Research Group.

Int J Urol. 2015 Feb;22(2):206-12. doi: 10.1111/iju.12654. Epub 2014 Oct 28.

28.

Diabetes and cardiovascular disease in older adults: current status and future directions.

Halter JB, Musi N, McFarland Horne F, Crandall JP, Goldberg A, Harkless L, Hazzard WR, Huang ES, Kirkman MS, Plutzky J, Schmader KE, Zieman S, High KP.

Diabetes. 2014 Aug;63(8):2578-89. doi: 10.2337/db14-0020.

29.

Association of exceptional parental longevity and physical function in aging.

Ayers E, Barzilai N, Crandall JP, Milman S, Verghese J.

Age (Dordr). 2014;36(4):9677. doi: 10.1007/s11357-014-9677-5. Epub 2014 Jul 5.

30.

GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence.

Eny KM, Lutgers HL, Maynard J, Klein BE, Lee KE, Atzmon G, Monnier VM, van Vliet-Ostaptchouk JV, Graaff R, van der Harst P, Snieder H, van der Klauw MM, Sell DR, Hosseini SM, Cleary PA, Braffett BH, Orchard TJ, Lyons TJ, Howard K, Klein R, Crandall JP, Barzilai N, Milman S, Ben-Avraham D; LifeLines Cohort Study Group; DCCT/EDIC Research Group, Wolffenbuttel BH, Paterson AD.

Diabetologia. 2014 Aug;57(8):1623-34. doi: 10.1007/s00125-014-3286-9. Epub 2014 Jun 17.

31.

The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men.

Snyder PJ, Ellenberg SS, Cunningham GR, Matsumoto AM, Bhasin S, Barrett-Connor E, Gill TM, Farrar JT, Cella D, Rosen RC, Resnick SM, Swerdloff RS, Cauley JA, Cifelli D, Fluharty L, Pahor M, Ensrud KE, Lewis CE, Molitch ME, Crandall JP, Wang C, Budoff MJ, Wenger NK, Mohler ER Rd, Bild DE, Cook NL, Keaveny TM, Kopperdahl DL, Lee D, Schwartz AV, Storer TW, Ershler WB, Roy CN, Raffel LJ, Romashkan S, Hadley E.

Clin Trials. 2014 Jun;11(3):362-375. doi: 10.1177/1740774514524032. Erratum in: Clin Trials. 2015 Jun;12(3):291.

32.

Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity.

Milman S, Atzmon G, Huffman DM, Wan J, Crandall JP, Cohen P, Barzilai N.

Aging Cell. 2014 Aug;13(4):769-71. doi: 10.1111/acel.12213. Epub 2014 Mar 12.

33.

Individuals with exceptional longevity manifest a delayed association between vitamin D insufficiency and cognitive impairment.

Milman S, Schulder-Katz M, Deluty J, Zimmerman ME, Crandall JP, Barzilai N, Melamed ML, Atzmon G.

J Am Geriatr Soc. 2014 Jan;62(1):153-8. doi: 10.1111/jgs.12601. Epub 2014 Jan 2.

34.

Resveratrol: therapeutic potential for improving cardiometabolic health.

Pollack RM, Crandall JP.

Am J Hypertens. 2013 Nov;26(11):1260-8. doi: 10.1093/ajh/hpt165. Epub 2013 Sep 11. Review.

PMID:
24025725
35.

Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes.

Epstein EJ, Osman JL, Cohen HW, Rajpathak SN, Lewis O, Crandall JP.

Diabetes Care. 2013 Aug;36(8):2280-5. doi: 10.2337/dc12-1693. Epub 2013 Apr 17.

36.

Exploring the promise of resveratrol: where do we go from here?

Crandall JP, Barzilai N.

Diabetes. 2013 Apr;62(4):1022-3. doi: 10.2337/db12-1788. No abstract available.

37.

The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease.

Sokol SI, Srinivas V, Crandall JP, Kim M, Tellides G, Lebastchi AH, Yu Y, Gupta AK, Alderman MH.

Vasc Med. 2012 Dec;17(6):394-404. doi: 10.1177/1358863X12466709. Erratum in: Vasc Med. 2013 Feb;18(1):51. Lebastchi, Amir [corrected to Lebastchi, Amir H].

PMID:
23184900
38.

Glycemic control and cardiovascular disease: what's a doctor to do?

Kishore P, Kim SH, Crandall JP.

Curr Diab Rep. 2012 Jun;12(3):255-64. doi: 10.1007/s11892-012-0268-5. Review.

39.

Family history of exceptional longevity is associated with lower serum uric acid levels in Ashkenazi Jews.

Lai JY, Atzmon G, Melamed ML, Hostetter TH, Crandall JP, Barzilai N, Bitzer M.

J Am Geriatr Soc. 2012 Apr;60(4):745-50. doi: 10.1111/j.1532-5415.2012.03902.x. Epub 2012 Mar 16.

40.

Pilot study of resveratrol in older adults with impaired glucose tolerance.

Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, Hawkins M, Cohen HW, Barzilai N.

J Gerontol A Biol Sci Med Sci. 2012 Dec;67(12):1307-12. doi: 10.1093/gerona/glr235. Epub 2012 Jan 4.

41.

Differential effects of low-carbohydrate and low-fat diets on inflammation and endothelial function in diabetes.

Davis NJ, Crandall JP, Gajavelli S, Berman JW, Tomuta N, Wylie-Rosett J, Katz SD.

J Diabetes Complications. 2011 Nov-Dec;25(6):371-6. doi: 10.1016/j.jdiacomp.2011.08.001. Epub 2011 Oct 27.

PMID:
22036100
42.

Relationship between vitamin D deficiency, post-challenge hyperglycemia, and endothelial function in healthy older adults.

Sokol SI, Grushko M, Srinivas VS, Crandall JP.

J Diabetes. 2012 Mar;4(1):102-3. doi: 10.1111/j.1753-0407.2011.00158.x. No abstract available.

PMID:
21936883
43.

Parental longevity and diabetes risk in the Diabetes Prevention Program.

Florez H, Ma Y, Crandall JP, Perreault L, Marcovina SM, Bray GA, Saudek CD, Barrett-Connor E, Knowler WC; Diabetes Prevention Program Research Group.

J Gerontol A Biol Sci Med Sci. 2011 Nov;66(11):1211-7. doi: 10.1093/gerona/glr114. Epub 2011 Aug 17.

44.

Menopause and risk of diabetes in the Diabetes Prevention Program.

Kim C, Edelstein SL, Crandall JP, Dabelea D, Kitabchi AE, Hamman RF, Montez MG, Perreault L, Foulkes MA, Barrett-Connor E; Diabetes Prevention Program Research Group.

Menopause. 2011 Aug;18(8):857-68. doi: 10.1097/gme.0b013e31820f62d0.

45.

Mechanisms of vascular complications in prediabetes.

Milman S, Crandall JP.

Med Clin North Am. 2011 Mar;95(2):309-25, vii. doi: 10.1016/j.mcna.2010.11.004. Review.

PMID:
21281835
46.

Cholesteryl ester transfer protein (CETP) genotype and reduced CETP levels associated with decreased prevalence of hypertension.

Schechter CB, Barzilai N, Crandall JP, Atzmon G.

Mayo Clin Proc. 2010 Jun;85(6):522-6. doi: 10.4065/mcp.2009.0594.

47.

Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program.

Krakoff J, Clark JM, Crandall JP, Wilson C, Molitch ME, Brancati FL, Edelstein SL, Knowler WC; Diabetes Prevention Program Research Group.

Obesity (Silver Spring). 2010 Sep;18(9):1762-7. doi: 10.1038/oby.2010.21. Epub 2010 Feb 25.

48.

Alcohol consumption and diabetes risk in the Diabetes Prevention Program.

Crandall JP, Polsky S, Howard AA, Perreault L, Bray GA, Barrett-Connor E, Brown-Friday J, Whittington T, Foo S, Ma Y, Edelstein SL; Diabetes Prevention Program Research Group.

Am J Clin Nutr. 2009 Sep;90(3):595-601. doi: 10.3945/ajcn.2008.27382. Epub 2009 Jul 29.

49.

Post-challenge hyperglycemia in older adults is associated with increased cardiovascular risk profile.

Crandall JP, Shamoon H, Cohen HW, Reid M, Gajavelli S, Trandafirescu G, Tabatabaie V, Barzilai N.

J Clin Endocrinol Metab. 2009 May;94(5):1595-601. doi: 10.1210/jc.2008-1829. Epub 2009 Feb 10.

50.

The role of iron in type 2 diabetes in humans.

Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat GC, Rohan TE, Hu FB.

Biochim Biophys Acta. 2009 Jul;1790(7):671-81. doi: 10.1016/j.bbagen.2008.04.005. Epub 2008 May 3. Review.

PMID:
18501198

Supplemental Content

Loading ...
Support Center